Invesaro

Stocks Comparison

Accendra Health vs Henry Schein: revenue, profit, margins and growth compared

Accendra Health brought in $2.8B of revenue in fiscal 2025, Henry Schein $13.2B in fiscal 2025. Revenue changed by +3.1% at Accendra Health and +4.0% at Henry Schein on the year before, so Henry Schein grew faster. Accendra Health kept -39.8% of its revenue as net profit, Henry Schein 3.0%. Free cash flow was -$292.7M at Accendra Health and $573M at Henry Schein.

Open the ACH pageOpen the HSIC page

Side by side, latest fiscal year

ACHHSIC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 27, 2025)
Revenue$2.8B$13.2B
Revenue growth+3.1%+4.0%
Net income-$1.1B$398M
Net margin-39.8%3.0%
Free cash flow-$292.7M$573M
Free cash flow margin-10.6%4.3%
Earnings per share (diluted)-$14.31$3.27
Cash$282M$156M
Debt$250M$2.3B
Price to earningsn/a26.4
Market value$54.4M$9.6B
Dividend yieldn/an/a
Rank by revenue in sector#89 of 523 · Health care#37 of 523 · Health care

Over the years

Revenue
ACH FY2018: $9.4BACH FY2019: $9.2BACH FY2020: $8.5BACH FY2021: $9.8BACH FY2022: $10BACH FY2023: $2.6BACH FY2024: $2.7BACH FY2025: $2.8BHSIC FY2018: $13.2BHSIC FY2019: $10BHSIC FY2020: $10.1BHSIC FY2021: $12.4BHSIC FY2022: $12.6BHSIC FY2023: $12.3BHSIC FY2024: $12.7BHSIC FY2025: $13.2BFY18FY19FY20FY21FY22FY23FY24FY25
ACH $2.8BHSIC $13.2B
Net income
ACH FY2018: -$437MACH FY2019: -$62.4MACH FY2020: $29.9MACH FY2021: $221.6MACH FY2022: $22.4MACH FY2023: -$41.3MACH FY2024: -$362.7MACH FY2025: -$1.1BHSIC FY2018: $535.9MHSIC FY2019: $694.7MHSIC FY2020: $404MHSIC FY2021: $631MHSIC FY2022: $538MHSIC FY2023: $416MHSIC FY2024: $390MHSIC FY2025: $398MFY18FY19FY20FY21FY22FY23FY24FY25
ACH -$1.1BHSIC $398M
Net margin
ACH FY2018: -4.6%ACH FY2019: -0.7%ACH FY2020: 0.4%ACH FY2021: 2.3%ACH FY2022: 0.2%ACH FY2023: -1.6%ACH FY2024: -13.5%ACH FY2025: -39.8%HSIC FY2018: 4.1%HSIC FY2019: 7.0%HSIC FY2020: 4.0%HSIC FY2021: 5.1%HSIC FY2022: 4.3%HSIC FY2023: 3.4%HSIC FY2024: 3.1%HSIC FY2025: 3.0%FY18FY19FY20FY21FY22FY23FY24FY25
ACH -39.8%HSIC 3.0%
Revenue growth
ACH FY2019: -2.2%ACH FY2020: -7.9%ACH FY2021: +15.4%ACH FY2022: +1.7%ACH FY2023: -74.4%ACH FY2024: +5.0%ACH FY2025: +3.1%HSIC FY2019: -24.4%HSIC FY2020: +1.3%HSIC FY2021: +22.6%HSIC FY2022: +2.0%HSIC FY2023: -2.4%HSIC FY2024: +2.7%HSIC FY2025: +4.0%FY19FY20FY21FY22FY23FY24FY25
ACH +3.1%HSIC +4.0%
Free cash flow
ACH FY2018: $70.7MACH FY2019: $123.7MACH FY2020: $288.8MACH FY2021: $83.2MACH FY2022: $166.9MACH FY2023: $568.3MACH FY2024: -$8.8MACH FY2025: -$292.7MHSIC FY2018: $613.4MHSIC FY2019: $577.9MHSIC FY2020: $550MHSIC FY2021: $631MHSIC FY2022: $506MHSIC FY2023: $353MHSIC FY2024: $700MHSIC FY2025: $573MFY18FY19FY20FY21FY22FY23FY24FY25
ACH -$292.7MHSIC $573M

Fiscal years as each company reports them; the two may end in different months.

Questions about Accendra Health and Henry Schein

Which is bigger by revenue, Accendra Health or Henry Schein?

Henry Schein is bigger by revenue: $13.2B in fiscal 2025, against $2.8B for Accendra Health in fiscal 2025.

Which keeps more of its revenue as profit, Accendra Health or Henry Schein?

Accendra Health had a net margin of -39.8% in fiscal 2025; Henry Schein had 3.0% in fiscal 2025.

Which grew revenue faster, Accendra Health or Henry Schein?

In their latest fiscal years revenue changed by +3.1% at Accendra Health and +4.0% at Henry Schein.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

Compare more companies